Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
T-502 by Inmunotek for Allergic Rhinitis: Likelihood of Approval
T-502 is under clinical development by Inmunotek and currently in Phase III for Allergic Rhinitis. According to GlobalData, Phase III...